TY - JOUR
T1 - Vinpocetine-induced stimulation of calcium-activated potassium currents in rat pituitary GH3 cells
AU - Wu, Sheng Nan
AU - Li, Hui Fang
AU - Chiang, Hung Ting
N1 - Funding Information:
The authors would like to thank Ms. Yen-Hua Hung for technical assistance. This work was supported by grants from the National Science Council (NSC-89-2320-B075B-016) and Kaohsiung Veterans General Hospital (VGHKS-89-15), Taiwan, ROC.
PY - 2001/4/1
Y1 - 2001/4/1
N2 - The effects of vinpocetine, an inhibitor of cyclic GMP phosphodiesterase, on ionic currents were examined in rat pituitary GH3 lactotrophs with the aid of the patch-clamp technique. In GH3 cells bathed in normal Tyrode's solution, vinpocetine (10 μM) reversibly increased the amplitude of Ca2+-activated K+ current (IK(Ca)) with an EC50 value of 4 μM. When the recording pipettes were filled with 10 mM EGTA, vinpocetine also stimulated IK(Ca). In the cell-attached configuration, application of vinpocetine to the bath increased the activity of large-conductance Ca2+-activated K+ (BKCa) channels. In excised membrane patches, application of vinpocetine (10 μM) to the bath did not change the single-channel conductance of BKCa channels; however, it did increase channel activity. In the inside-out configuration, neither 8-bromo cyclic GMP nor YC-1 applied intracellularly affected BKCa channel activity. The vinpocetine-induced change in the kinetic behavior of BKCa channels was due to an increase in mean open time and a decrease in mean closed time. Vinpocetine (10 μM) caused a leftward shift in the midpoint for the voltage-dependent opening. Under the current-clamp mode, vinpocetine (10 μM) decreased the firing rate of spontaneous action potentials induced by thyrotropin-releasing hormone (10 μM) in GH3 cells. In pheochromocytoma PC12 cells, vinpocetine (10 μM) applied intracellularly also enhanced the activity of BKCa channels without altering single-channel conductance. Thus, the present study suggests that vinpocetine-mediated stimulation of IK(Ca) may result from the direct activation of BKCa channels and indirectly from elevated cytosolic Ca2+.
AB - The effects of vinpocetine, an inhibitor of cyclic GMP phosphodiesterase, on ionic currents were examined in rat pituitary GH3 lactotrophs with the aid of the patch-clamp technique. In GH3 cells bathed in normal Tyrode's solution, vinpocetine (10 μM) reversibly increased the amplitude of Ca2+-activated K+ current (IK(Ca)) with an EC50 value of 4 μM. When the recording pipettes were filled with 10 mM EGTA, vinpocetine also stimulated IK(Ca). In the cell-attached configuration, application of vinpocetine to the bath increased the activity of large-conductance Ca2+-activated K+ (BKCa) channels. In excised membrane patches, application of vinpocetine (10 μM) to the bath did not change the single-channel conductance of BKCa channels; however, it did increase channel activity. In the inside-out configuration, neither 8-bromo cyclic GMP nor YC-1 applied intracellularly affected BKCa channel activity. The vinpocetine-induced change in the kinetic behavior of BKCa channels was due to an increase in mean open time and a decrease in mean closed time. Vinpocetine (10 μM) caused a leftward shift in the midpoint for the voltage-dependent opening. Under the current-clamp mode, vinpocetine (10 μM) decreased the firing rate of spontaneous action potentials induced by thyrotropin-releasing hormone (10 μM) in GH3 cells. In pheochromocytoma PC12 cells, vinpocetine (10 μM) applied intracellularly also enhanced the activity of BKCa channels without altering single-channel conductance. Thus, the present study suggests that vinpocetine-mediated stimulation of IK(Ca) may result from the direct activation of BKCa channels and indirectly from elevated cytosolic Ca2+.
UR - http://www.scopus.com/inward/record.url?scp=0035313053&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035313053&partnerID=8YFLogxK
U2 - 10.1016/S0006-2952(01)00553-6
DO - 10.1016/S0006-2952(01)00553-6
M3 - Article
C2 - 11274974
AN - SCOPUS:0035313053
SN - 0006-2952
VL - 61
SP - 877
EP - 892
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 7
ER -